Back to results
US 2022/0178914 A1Published application
Lithium heparin as a blocking agent
AssigneeOrtho-Clinical Diagnostics, Inc.
InventorsBrett Hirsch, Paul Contestable
Life of this patent
Estimating the term…
Abstract
Described herein are blocking agents that can be used in diagnostic assays to prevent false positive results.
Claims14
An immunoassay reagent comprising:
- one or more binding agent(s) in a diluent;
- and lithium heparin in an amount sufficient to reduce non-specific binding in an assay.
Dependencies are inferred from the claim text.